Showing results (1551-1560 of 1,591) with videos related to
Sort By:
Pageof 160
Scientific Reports|September 30, 2024
Trends in 5-year cancer survival disparities by race and ethnicity in the US between 2002-2006 and 2015-2019Chongfa Chen, Lingdi Yin, Chunhui Lu, et al.Cancer Cell|September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trialMu-Chen Zhang, Shuang Tian, Di Fu, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 12, 2019
Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resectionDing-Hui Dong, Xu-Feng Zhang, Alexandra G Lopez-Aguiar, et al.Nature Communications|October 21, 2017
MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonistsCong Lv, Fengyin Li, Xiang Li, et al.Annals of Surgical Oncology|November 6, 2023
Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral SubtypeTao Wei, Jianfeng Lu, Xue-Lian Xiao, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 27, 2017
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor HepatectomyXu-Feng Zhang, Fabio Bagante, Jeffery Chakedis, et al.Clinical and Translational Medicine|April 23, 2025
Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational studyRong Shen, Wei-Guo Cao, Li Wang, et al.Surgery|October 4, 2018
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study GroupXu-Feng Zhang, Zheng Wu, Jordan Cloyd, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 12, 2025
Perioperative dynamic changes of systemic inflammatory biomarkers predict tumor recurrence following curative-intent resection of hepatocellular carcinomaJingming Lu, Fumin Wang, Yaoxing Ren, et al.Surgery|February 6, 2018
Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinomaXu-Feng Zhang, Fabio Bagante, Qinyu Chen, et al.Pageof 160